Scarica l'app Stockscreener
0.8005
3.24%
0.0205
Precedente Chiudi:
$0.78
Aprire:
$0.8
Volume 24 ore:
62,565
Relative Volume:
0.06
Capitalizzazione di mercato:
$5.69M
Reddito:
$5.75M
Utile/perdita netta:
$-38.96M
Rapporto P/E:
-0.0642
EPS:
-12.47
Flusso di cassa netto:
$-32.63M
1 W Prestazione:
-0.07%
1M Prestazione:
-47.71%
6M Prestazione:
-78.53%
1 anno Prestazione:
-88.48%
Intervallo 1D:
$0.785
$0.81
Intervallo di 1 settimana:
$0.74
$0.833
Portata 52W:
$0.74
$20.60
Kala Bio Inc Stock (KALA) Company Profile
Nome
Kala Bio Inc
Settore
Industria
Telefono
781-996-5252
Indirizzo
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Confronta KALA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
0.81 | 5.48M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
638.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.90 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.39 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.24 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Downgrade | Mizuho | Outperform → Neutral |
| 2025-09-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-29 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-09-08 | Iniziato | Mizuho | Outperform |
| 2025-07-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-03-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-08-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-07-23 | Iniziato | Northland Capital | Outperform |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2020-05-27 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Kala Bio Inc Borsa (KALA) Ultime notizie
Risk vs reward if holding onto KALA BIO Inc.M&A Rumor & High Win Rate Trade Tips - newser.com
Real time scanner hits for KALA BIO Inc. explainedJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Will KALA BIO Inc. stock sustain high P E ratiosMarket Performance Recap & Consistent Profit Alerts - newser.com
How supply chain issues affect KALA BIO Inc. stockJuly 2025 Sentiment & Community Trade Idea Sharing - newser.com
Applying Elliott Wave Theory to KALA BIO Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com
Will KALA BIO Inc. outperform the marketJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Is KALA BIO Inc. stock a contrarian buyJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - newser.com
Real time alert setup for KALA BIO Inc. performanceJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
When is the best time to exit KALA BIO Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
How hedge fund analytics apply to KALA BIO Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com
What drives KALA BIO Inc stock priceUtilities Sector Analysis & Rapid Portfolio Expansion - earlytimes.in
Is KALA BIO Inc a good long term investmentCash Flow Trends & Identify Breakout Stocks - earlytimes.in
Chart based exit strategy for KALA BIO Inc.July 2025 Snapshot & Safe Capital Investment Plans - newser.com
KALA BIO Inc. stock trend outlook and recovery pathJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Will KALA BIO Inc. stock deliver shareholder value2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Applying big data sentiment scoring on KALA BIO Inc.Weekly Investment Report & Fast Momentum Entry Tips - newser.com
Is KALA BIO Inc. stock trading at a premium valuationMarket Risk Report & Verified Technical Trade Signals - newser.com
A Heavy Trading Day Sends Biotech And Finance Stocks Reeling - Finimize
Will KALA BIO Inc. stock outperform value stocks2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Using fundamentals and technicals on KALA BIO Inc.Weekly Market Outlook & Low Risk High Win Rate Stock Picks - newser.com
Volatility clustering patterns for KALA BIO Inc.M&A Rumor & AI Optimized Trade Strategies - newser.com
Measuring KALA BIO Inc.’s beta against major indicesQuarterly Trade Review & Growth Focused Entry Reports - newser.com
Will KALA BIO Inc. stock recover after recent dropJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com
Detecting support and resistance levels for KALA BIO Inc.Earnings Trend Report & High Conviction Investment Ideas - newser.com
Why KALA BIO Inc. stock is recommended by analystsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Kala Bio Inc Azioni (KALA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kala Bio Inc Azioni (KALA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 22 '25 |
Sale |
0.83 |
32,230 |
26,751 |
29,873 |
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Oct 23 '25 |
Sale |
0.82 |
967 |
793 |
28,906 |
| Bazemore Todd | Director |
Oct 22 '25 |
Sale |
0.83 |
47,768 |
39,647 |
35,932 |
| Brazzell Romulus K | SEE REMARKS |
Oct 22 '25 |
Sale |
0.83 |
46,748 |
38,801 |
35,952 |
| Kharabi Darius | CHIEF BUSINESS OFFICER |
Oct 22 '25 |
Sale |
0.83 |
20,806 |
17,269 |
41,760 |
0.21%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):